Seven things we learned from our latest cancer treatment data
PHE, in partnership with Cancer Research UK, have published new data showing how chemotherapy, radiotherapy and surgery rates vary for different groups of patients in England.
Anna Fry
Anna is a cancer data analyst on the partnership between Cancer Research UK and Public Health England, working with data from PHE’s National Cancer Registration and Analysis Service (NCRAS). Her current work concentrates on understanding cancer treatment variation in England. She joined the partnership in 2015, following a Masters in Global Health Science at the University of Oxford.